Acetate Utilization Promotes Hormone Therapy Resistance in Prostate Cancer through Neuroendocrine Differentiation

Tumor fatty acid (FA) metabolic plasticity plays a pivotal role in resistance to therapy and poses limitations to anticancer strategies. In this study, our aim is to uncover the role of acetate metabolism in neurodifferentiation (NED)-mediated castration-resistant prostate cancer (CRPC).